We serve Chemical Name:6-fluorobenzo[d]isoxazole-3-carboxylic acid CAS:894789-43-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:6-fluorobenzo[d]isoxazole-3-carboxylic acid
CAS.NO:894789-43-6
Synonyms:6-fluorobenzo[d]isoxazole-3-carboxylic acid
Molecular Formula:C8H4FNO3
Molecular Weight:181.12100
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:63.33000
Exact Mass:181.01800
LogP:1.66510
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 6-fluorobenzo[d]isoxazole-3-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-fluorobenzo[d]isoxazole-3-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-fluorobenzo[d]isoxazole-3-carboxylic acid Use and application,6-fluorobenzo[d]isoxazole-3-carboxylic acid technical grade,usp/ep/jp grade.
Related News: An effective treatment for Alzheimer��s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally. 6-fluorobenzo[d]isoxazole-3-carboxylic acid manufacturer He pointed out that Taiwan had 10 confirmed cases, versus more than 14,000 in mainland China. 6-fluorobenzo[d]isoxazole-3-carboxylic acid supplier Vietnam recently barred almost all flights to and from mainland China, Hong Kong and Macau until May 1, according to the United States Federal Aviation Administration. 6-fluorobenzo[d]isoxazole-3-carboxylic acid vendor Vietnam recently barred almost all flights to and from mainland China, Hong Kong and Macau until May 1, according to the United States Federal Aviation Administration. 6-fluorobenzo[d]isoxazole-3-carboxylic acid factory An effective treatment for Alzheimer��s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally.